Blog

FDA OKs Northera for Hypotension

Share on FacebookShare on LinkedInTweet about this on TwitterPin on PinterestEmail this to someoneShare on Google+

(MedPage Today) — The FDA has approved droxidopa (Northera) for the treatment of neurogenic orthostatic hypotension, a rare disease that results in a drop in blood pressure when patients try to stand up.

Read More

Biopsy May Be Avoidable With IPF Imaging Alone

Share on FacebookShare on LinkedInTweet about this on TwitterPin on PinterestEmail this to someoneShare on Google+

(MedPage Today) — Idiopathic pulmonary fibrosis (IPF) diagnosis in the absence of the tell-tale honeycombing pattern on radiology might not always require surgical lung biopsy, a study showed.

Read More

Women Prefer Implants for Breast Reconstruction (CME/CE)

Share on FacebookShare on LinkedInTweet about this on TwitterPin on PinterestEmail this to someoneShare on Google+

(MedPage Today) — Breast reconstruction after mastectomy increased significantly, but more than a third of eligible patients did not have the procedure during the 10 years ending in 2007, a review of more than 20,000 cases showed.

Read More

Zapping Artery Tops Drugs for Controlling Afib (CME/CE)

Share on FacebookShare on LinkedInTweet about this on TwitterPin on PinterestEmail this to someoneShare on Google+

(MedPage Today) — Paroxysmal atrial fibrillation recurred significantly less often in patients initially treated with radiofrequency ablation (RFA) instead of medication, results of a randomized trial showed.

Read More

Ratings a Factor When Choosing Physician

Share on FacebookShare on LinkedInTweet about this on TwitterPin on PinterestEmail this to someoneShare on Google+

(MedPage Today) — Nearly three out of five people said a physician’s rating on a website was at least a somewhat important factor when choosing a doctor, survey results published Tuesday found.

Read More

Celexa Eases Alzheimer’s Agitation, but Safety Unclear (CME/CE)

Share on FacebookShare on LinkedInTweet about this on TwitterPin on PinterestEmail this to someoneShare on Google+

(MedPage Today) — A well-known antidepressant reduced agitation in people with probable Alzheimer’s disease, but with some adverse cardiac and cognitive effects, researchers reported.

Read More

Outpatient Surgery: Is Infection a Real Risk? (CME/CE)

Share on FacebookShare on LinkedInTweet about this on TwitterPin on PinterestEmail this to someoneShare on Google+

(MedPage Today) — The chance of a clinically significant infection after ambulatory surgery is relatively small; nonetheless, outpatient surgery related infections account for roughly one in five healthcare-associated infections.

Read More

Rituxan Offers Little Help for Sjogren’s

Share on FacebookShare on LinkedInTweet about this on TwitterPin on PinterestEmail this to someoneShare on Google+

(MedPage Today) — Treatment for primary Sjogren’s syndrome with the B-cell depleting antibody rituximab (Rituxan) failed to provide statistically significant improvements, despite the increasing evidence for B cells in the pathogenesis of this disorder, French researchers reported.

Read More

California Weighs Coverage for Illegal Immigrants

Share on FacebookShare on LinkedInTweet about this on TwitterPin on PinterestEmail this to someoneShare on Google+

(MedPage Today) — In a push to cover immigrants excluded from the nation’s health reform law, a California state senator has proposed legislation that would offer health insurance for all Californians, including those living here illegally.

Read More

Treating HCV — Is the Price Right?

Share on FacebookShare on LinkedInTweet about this on TwitterPin on PinterestEmail this to someoneShare on Google+

(MedPage Today) — New drugs on the horizon hold out the promise of being able to cure up to 90% of people with chronic hepatitis C (HCV). They are also promising to be expensive.

Read More